About Erin Lopata, RPh, PharmD, MPH, Senior Director, Access Experience Team, Precision for Value

This author has not yet filled in any details.
So far Erin Lopata, RPh, PharmD, MPH, Senior Director, Access Experience Team, Precision for Value has created 2 blog entries.

Regional Health Plans: COVID-19 and 2021 Commercial Formulary Decisions

As the country continues to battle COVID-19, regional health plans are beginning to shift focus from pandemic response to 2021 formulary planning. While they will continue to adapt, there will undoubtedly be lasting downstream impacts and challenges from COVID-19. Erin Lopata discusses the response expected for regional health plans.

The Latest on Biosimilar Interchangeability

In May 2019, the FDA released guidance to clarify the level of evidence required from manufacturers to support interchangeability between a biosimilar and the reference product. Erin Lopata explains how this may impact stakeholders, and how price and utilization could be influenced by increased competition in the biologics market.